课题基金 / 基金详情

SAFETY, TOLERANCE OF RHHUIL-10 IN PATIENTS WITH ACTIVE CROHN'S DISEASE

SAFETY, TOLERANCE OF RHHUIL-10 IN PATIENTS WITH ACTIVE CROHN'S DISEASE
RHHUIL-10 对活动性克罗恩病患者的安全性和耐受性
批准号：
6245060
负责人：
KIM L ISAACS
金额：
$1.34万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-01-06 至 1997-11-30
来源：
https://reporter.nih.gov/project-details/6245060
关键词：
Crohn's disease chronic disease /disorder clinical research clinical trials dosage drug administration routes drug screening /evaluation drug tolerance gastrointestinal disorder chemotherapy human subject human therapy evaluation interleukin 10

项目摘要

项目成果

KIM L ISAACS的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of the study is to study the efficacy, safety and tolerance of multiple doses of subcutaneous SCH 5200 in patients with chronically active Crohn's Disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: MULTI-SITE TRIAL OF AZATHIOPRINE DOSING IN CROHN'S DISEASE
MULTI-SITE TRIAL OF AZATHIOPRINE DOSING IN CROHN'S DISEASE
AZATHIOPRINE LOADING TO DECREASE RESPONSE TIME IN CROHN'S DISEASE
TAK 603/A 165646 IN PATIENTS W/ CROHNS DISEASE